GP-Act III Acquisition Corp. (GPAT) Revenue History
Annual and quarterly revenue from 2020 to present
GPAT Revenue Over Time (2020–2025)
GPAT Revenue Growth History
- FY2020 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
| Q1 2024 | $0 | — |
GPAT Revenue Analysis (2020–2025)
Current Revenue & Growth
As of June 13, 2026, GP-Act III Acquisition Corp. (GPAT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue
Historical Growth Trajectory
GPAT's historical revenue data shows various trends over time.
Peer Comparison
Compared to Financial Services sector peers — including PSFE (+3.3% YoY), ACIC (+13.1% YoY), and GS. Compare GPAT vs PSFE →
GPAT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $0 | - | - | - | ||
| $1.7B | +3.3% | +3.6% | 7.2% | ||
| $335M | +13.1% | -16.9% | 42.6% | ||
| $125.1B | - | - | 17.5% | ||
| $115.0B | - | - | 19.1% | ||
| $279.7B | - | - | 26.0% |
GPAT Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-551,918 | - |
| 2024 | $0 | - | $0 | - | $-565,000 | - |
| 2023 | $0 | - | $0 | - | $-14,041 | - |
| 2022 | $0 | - | $0 | - | $-30,840 | - |
| 2020 | $0 | - | $0 | - | $-3,970 | - |
What if you invested $1,000 in GPAT back in 2020?
Total return with dividends reinvested · 6+ years of data
Calculate ReturnsHow much would $100/month in GPAT be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs GPAT Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationGPAT vs BRK-B — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Berkshire Hathaway Inc..
Compare NowGPAT — Frequently Asked Questions
Quick answers to the most common questions about buying GPAT stock.
Is GPAT's revenue growth accelerating or slowing?
GPAT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is GPAT's revenue history from 2020 to 2026?
GP-Act III Acquisition Corp. (GPAT) revenue history spans 2020 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is GPAT's long-term revenue growth rate (CAGR)?
GP-Act III Acquisition Corp.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for GPAT.
Why does GPAT's quarterly revenue fluctuate?
GPAT quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. GP-Act III Acquisition Corp.'s revenue data from 2020 to 2026 shows full historical quarterly detail on this page.
How is GPAT's revenue distributed by segment?
GPAT reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does GPAT's revenue compare to industry peers?
GP-Act III Acquisition Corp. (GPAT) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.